Competition 18 – Stroke and Technology – Phase 1 – Panel list

The funding panels for SBRI Healthcare are multidisciplinary, comprising clinical, commercial and technical expertise as well as representatives from the Academic Health Science Networks (AHSN) and NHS England.


Dr Glenn Wells (Chair) Director of Strategy & Planning at the Medical Research Council
  • Skilled in Research and Development (R&D), Medical Devices, Life Sciences, Business Development, and Strategic Planning. 
  • Strong business development professional with a Doctor of Philosophy – PhD focused in Cell/Cellular and Molecular Biology from University College London (UCL).
Dr Helen Meese

(Deputy Chair)

CEO at The Care Machine Ltd
  • Expertise: Strategic Planning, Operational & Project Management, Tendering & Proposal Preparation, Requirements Capture.
  • Consultant for Engineering, Design & Manufacture (for medical devices & equipment) and Policy, Advocacy & Public affairs in Healthcare & Medtech.
Ms Hilary Fanning Director of Research Development and Innovation at University Hospitals Birmingham NHS Foundation Trust
  • Assessment of pre-regulation device utility for adoption into clinical and operational pathways
  • Management of change processes, transition of novel into Business as usual
Dr Rebecca Fisher Principal Research Fellow, University of Nottingham
  • Stroke rehabilitation, early supported discharge, service development, implementation, health services research.
  • Implementation and evaluation of complex interventions in real world settings. 
Mr Liam Gascoigne-Cohen


Research Analyst, Healthcare, SP Angel

S.P. Angel Corporate Finance LLP

  • Sell-side analyst responsible for smallcap healthcare research and supporting public/private transactions. 
  • BSc Biology from Bristol University and MSc Biotechnology from Imperial College London.
Dr David Hargroves Consultant Physician and Clinical Lead for Stroke Medicine at East Kent Hospitals University NHS Foundation Trust
  • Consultant for over 10 years with expertise in hyper acute stroke care and medicine, and imaging in stroke care.
Professor Liudi Jiang Professor of Materials and Electromechanical Systems at University of Southampton
  • Biomedical devices, rehabilitation engineering, intelligent sensors, biomechanics, body interface systems and digital health.
Mr Chris May Director at Mayden House Limited
  • Speciality in healthcare planning and information analysis and has concentrated on the health service for the past 30 years.
Professor Roma Maguire Professor of Digital Health and Care at University of Strathclyde
  • Digital health/care, remote patient monitoring, clinical decision support, patient experience, evidence based care, cancer, chronic disease, dementia.
  • Human factors, AI Digital health implementation/evaluation.
Mr Steve Parr Healthcare and Medtech Lead at Enterprise M3 Limited
  • Medtech, digital health and the NHS. 
  • Commercialisation, product R&D, marketing, sales, co. funding, value propositions and market access.
Mr Andrew Payne Manager at NHS Shared Business Services (Salford)
  • Public sector procurement in the NHS across clinical and IT categories.
Professor Valerie Pomeroy Professor of Neurorehabilitation at University of East Anglia
  • Stroke rehabilitation, physiotherapy and movement analysis.
Dr Guy Rooney Medical Director at Oxford AHSN
  • Currently leading on supporting innovation adoption and strengthening clinical engagement with emerging integrated care systems at OXAHSN. 
  • Previously medical director at Great Western Hospitals in Swindon where he worked for almost 20 years. He has been a consultant in sexual health and HIV since 1999 and is also medical specialist advisor at the Oxfordshire Clinical Commissioning Group.
Professor Harm van Marwijk Head of the Department of Primary Care and Public Health at Brighton and Sussex Medical School
  • Harm stimulates collaborations and connections in care, teaching and research, focusing on generalist medicine and research methods.
  • Expertise in general practice, digital innovation, randomised trials and qualitative methods.
Professor Tony Young  National Clinical Lead for Innovation at IRLS, NHSE
  • Clinical Speciality Urology. 
  • Expertise: all aspects of healthcare and life science innovation and has acted as external examiner for PhD’s in ML at UCL.
Dr Laura Fenner PPIE Representative N/A